相关实验视频
Updated: Jul 6, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
葡萄糖传感器具有低血糖预测报警:改善了1型糖尿病青少年的血糖控制
Marco Marigliano1, Claudia Piona1, Valentina Mancioppi1
1Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, Department of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.
Diabetes, obesity & metabolism
|January 4, 2024
概括
实时连续血糖监测与预测警报显著减少了1型糖尿病青少年的低血糖事件. 这项技术改善了血糖控制,降低了严重低血糖的风险.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
- 医疗技术 医疗技术 医学技术
背景情况:
- 低血糖事件是1型糖尿病中微血管和宏血管并发症的重要危险因素.
- 有效的葡萄糖管理对于预防1型糖尿病青少年的长期并发症至关重要.
研究的目的:
- 评估实时连续血糖监测 (RT-CGM) 具有预测警报 (PA) 的有效性,以减少1型糖尿病 (AwD) 青少年在范围以下 (<70 mg/dl) 的时间.
主要方法:
- 一项交叉,单心,随机研究,涉及20名患有1型糖尿病的青少年.
- 参与者被随机分配到RT-CGM的序列,用于低血糖的值 (AoT) 或预测警报 (PA) 的警报.
- 统计分析使用双向重复测量ANOVA来比较PA与AoT组,并考虑转移效应.
主要成果:
- 使用RT-CGM与PA的青少年在严重低血糖症 (<54 mg/dl) 和整体低血糖症 (<70 mg/dl) 中的时间显著减少.
- 与AoT组相比,PA组的血糖危险指数较低.
- 这些发现表明,通过使用预测警报,血糖控制得到了显著改善.
结论:
- 带有低血糖预测报警的RT-CGM技术可以显著降低1型糖尿病青少年低血糖事件的发生率.
- 这种技术进步为这种患者群体提供了更好的葡萄糖控制质量.
- 这项研究支持将预测报警技术整合到青少年糖尿病管理中.
相关概念视频
Hypoglycemia and Glucagon
264
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
264
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Oral Hypoglycemic Agents: Glinides
156
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
156
Diabetes: Symptoms, Diagnosis, and Complications
549
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
549
Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K

